New concepts and new weapons in implant infections

Research output: Contribution to journalArticle

Abstract

Molecular studies have cast light on new facts about the virulence factors of bacteria responsible for implant infections. Recently, the biofilm matrix has been shown to include a variety of important structural components, including DNA, in addition to polysaccharides and proteins. This finding has stimulated interest in substances able to disrupt biofilms by attacking both the poly-N-acetylglucosamine surface polysaccharide (PNAG) and the extracellular DNA (eDNA), namely, dispersin B, a PNAG-degrading enzyme, and DNase I. The therapeutic potential of these enzymes are reviewed in this issue of IJAO, as well as the ability of the excretions/secretions of the medicinal maggot Lucilia sericata to disrupt Staphylococcus epidermidis biofilms. The activity of bacterial proteases causes the release of eDNA, critical for the early development of biofilms. This complex process, including suicidal and fratricidal mechanisms, is also presented in the current issue of IJAO. The different sensitivities of S. aureus and S. epidermidis to enzymatic anti-biofilm agents and to the host's first line of defense, as well as the importance of knowing the cascade of regulatory genes in bacteria so as to interfere with biofilm production using gene therapy or quorum sensing inhibitors are also discussed in this issue. Other innovative approaches consist in disrupting biofilms by exposing them to photodynamic substances and simultaneously to visible light, and in coating biomaterial surfaces with organic molecules to prevent protein adsorption and biofilm formation.

Original languageEnglish
Pages (from-to)533-536
Number of pages4
JournalInternational Journal of Artificial Organs
Volume32
Issue number9
Publication statusPublished - 2009

Fingerprint

Weapons
Biofilms
Infection
Polysaccharides
DNA
Staphylococcus epidermidis
Acetylglucosamine
Bacteria
Enzymes
Proteins
Gene therapy
Quorum Sensing
Deoxyribonuclease I
Biocompatible Materials
Virulence Factors
Regulator Genes
Biomaterials
Genetic Therapy
Adsorption
Larva

Keywords

  • Anti-biofilm agents
  • Dispersin-B
  • DNase I
  • Extracellular DNA (eDNA)
  • Implant infections
  • Poly-N-acetylglucosamine surface polysaccharide (PNAG)
  • Quorum sensing inhibitors
  • Staphylococcus aureus
  • Staphylococcus epidermidis

ASJC Scopus subject areas

  • Bioengineering
  • Biomedical Engineering
  • Biomaterials
  • Medicine (miscellaneous)

Cite this

New concepts and new weapons in implant infections. / Arciola, Carla Renata.

In: International Journal of Artificial Organs, Vol. 32, No. 9, 2009, p. 533-536.

Research output: Contribution to journalArticle

@article{3aa9689d408a4be8a75a8fbcb41ba2c4,
title = "New concepts and new weapons in implant infections",
abstract = "Molecular studies have cast light on new facts about the virulence factors of bacteria responsible for implant infections. Recently, the biofilm matrix has been shown to include a variety of important structural components, including DNA, in addition to polysaccharides and proteins. This finding has stimulated interest in substances able to disrupt biofilms by attacking both the poly-N-acetylglucosamine surface polysaccharide (PNAG) and the extracellular DNA (eDNA), namely, dispersin B, a PNAG-degrading enzyme, and DNase I. The therapeutic potential of these enzymes are reviewed in this issue of IJAO, as well as the ability of the excretions/secretions of the medicinal maggot Lucilia sericata to disrupt Staphylococcus epidermidis biofilms. The activity of bacterial proteases causes the release of eDNA, critical for the early development of biofilms. This complex process, including suicidal and fratricidal mechanisms, is also presented in the current issue of IJAO. The different sensitivities of S. aureus and S. epidermidis to enzymatic anti-biofilm agents and to the host's first line of defense, as well as the importance of knowing the cascade of regulatory genes in bacteria so as to interfere with biofilm production using gene therapy or quorum sensing inhibitors are also discussed in this issue. Other innovative approaches consist in disrupting biofilms by exposing them to photodynamic substances and simultaneously to visible light, and in coating biomaterial surfaces with organic molecules to prevent protein adsorption and biofilm formation.",
keywords = "Anti-biofilm agents, Dispersin-B, DNase I, Extracellular DNA (eDNA), Implant infections, Poly-N-acetylglucosamine surface polysaccharide (PNAG), Quorum sensing inhibitors, Staphylococcus aureus, Staphylococcus epidermidis",
author = "Arciola, {Carla Renata}",
year = "2009",
language = "English",
volume = "32",
pages = "533--536",
journal = "International Journal of Artificial Organs",
issn = "0391-3988",
publisher = "Wichtig Publishing",
number = "9",

}

TY - JOUR

T1 - New concepts and new weapons in implant infections

AU - Arciola, Carla Renata

PY - 2009

Y1 - 2009

N2 - Molecular studies have cast light on new facts about the virulence factors of bacteria responsible for implant infections. Recently, the biofilm matrix has been shown to include a variety of important structural components, including DNA, in addition to polysaccharides and proteins. This finding has stimulated interest in substances able to disrupt biofilms by attacking both the poly-N-acetylglucosamine surface polysaccharide (PNAG) and the extracellular DNA (eDNA), namely, dispersin B, a PNAG-degrading enzyme, and DNase I. The therapeutic potential of these enzymes are reviewed in this issue of IJAO, as well as the ability of the excretions/secretions of the medicinal maggot Lucilia sericata to disrupt Staphylococcus epidermidis biofilms. The activity of bacterial proteases causes the release of eDNA, critical for the early development of biofilms. This complex process, including suicidal and fratricidal mechanisms, is also presented in the current issue of IJAO. The different sensitivities of S. aureus and S. epidermidis to enzymatic anti-biofilm agents and to the host's first line of defense, as well as the importance of knowing the cascade of regulatory genes in bacteria so as to interfere with biofilm production using gene therapy or quorum sensing inhibitors are also discussed in this issue. Other innovative approaches consist in disrupting biofilms by exposing them to photodynamic substances and simultaneously to visible light, and in coating biomaterial surfaces with organic molecules to prevent protein adsorption and biofilm formation.

AB - Molecular studies have cast light on new facts about the virulence factors of bacteria responsible for implant infections. Recently, the biofilm matrix has been shown to include a variety of important structural components, including DNA, in addition to polysaccharides and proteins. This finding has stimulated interest in substances able to disrupt biofilms by attacking both the poly-N-acetylglucosamine surface polysaccharide (PNAG) and the extracellular DNA (eDNA), namely, dispersin B, a PNAG-degrading enzyme, and DNase I. The therapeutic potential of these enzymes are reviewed in this issue of IJAO, as well as the ability of the excretions/secretions of the medicinal maggot Lucilia sericata to disrupt Staphylococcus epidermidis biofilms. The activity of bacterial proteases causes the release of eDNA, critical for the early development of biofilms. This complex process, including suicidal and fratricidal mechanisms, is also presented in the current issue of IJAO. The different sensitivities of S. aureus and S. epidermidis to enzymatic anti-biofilm agents and to the host's first line of defense, as well as the importance of knowing the cascade of regulatory genes in bacteria so as to interfere with biofilm production using gene therapy or quorum sensing inhibitors are also discussed in this issue. Other innovative approaches consist in disrupting biofilms by exposing them to photodynamic substances and simultaneously to visible light, and in coating biomaterial surfaces with organic molecules to prevent protein adsorption and biofilm formation.

KW - Anti-biofilm agents

KW - Dispersin-B

KW - DNase I

KW - Extracellular DNA (eDNA)

KW - Implant infections

KW - Poly-N-acetylglucosamine surface polysaccharide (PNAG)

KW - Quorum sensing inhibitors

KW - Staphylococcus aureus

KW - Staphylococcus epidermidis

UR - http://www.scopus.com/inward/record.url?scp=70549086645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70549086645&partnerID=8YFLogxK

M3 - Article

C2 - 19856268

AN - SCOPUS:70549086645

VL - 32

SP - 533

EP - 536

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 9

ER -